Cellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme

DISEASE CHARACTERISTICS:

* Diagnosis of primary malignant glioblastoma multiforme (i.e., grade IV anaplastic astrocytoma)
* Primary treatment (surgery, radiation, and/or chemotherapy) has been completed
* Candidate for surgery and willing to undergo craniotomy
* No progressive or recurrent disease
* No residual disease that requires reoperation, additional gamma therapy, or other modality

PATIENT CHARACTERISTICS:

* ECOG performance status (PS) 0-2 OR Karnofsky PS 70-100% (i.e., if symptomatic, bedridden \< half of a waking day)
* Life expectancy ≥ 2 months
* Not pregnant
* Negative pregnancy test
* U.S. residents only
* No hematopoietic, hepatic, renal, cardiovascular, or pulmonary laboratory values or other medical circumstances that would preclude surgery or aldesleukin therapy
* No serious concurrent medical or psychiatric illness that would preclude informed consent or study treatment

PRIOR CONCURRENT THERAPY:

* See Disease Characteristics
* At least 4 weeks since prior anticancer therapy and recovered
* Prior stereotactic or gamma knife radiosurgery allowed